|
|
|
|
|
|
In addition to Apollo Life Sciences development and finished dosage form capabilities, we boast a state-of-the-art cGMP compliant API manufacturing facility approved by the USSFDA, UKMHRA& TGA.
Research Capabilities & Attributes:
R&D team consisting 50+ scientists of which 15+ scientists are PhD''s
API R&D team is supported by a dedicated analytical group comprising 25 scientists, of which 10 are Ph.Ds.
05 years of API process research experience
Excellent History of precise and timely implementation of projects
Development of solutions to generate robust API processes.
Equilibrium between low cost and high value added work
API''s developed to date is 150+
Latest formulation drugs developed 375+
Latest Anticancer/Cancer injectable / Oral drugs developed 45+
HIV drugs First research developed in INDIA 6+ |
|
|
| DEXTROMETHORPHAN, Dextromethorthane hydrobromide, DEXTROPROPOXYPHENE, dextropropoxythene Hcl , Amitriptylinehydrochloride, acetylCapatopril, Azithromycin, Captopril, Cefatazibime, cefotaxime, ceftazidime, cefuroximeacid, cefuroxime acid, celecoxib |
|
|
| Company : |
Apollo Life Sciences India |
| Email: |
Contact us |
| URL: |
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
India |
| Address : |
*********
|
|
|
|
|
|
